Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection

Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection....

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 2; p. e29552
Main Authors Fu, Simei, Xu, Jie, Li, Xianbo, Xie, Yongfei, Qiu, Yefeng, Du, Xinying, Yu, Shuang, Bai, Yaoxia, Chen, Yanfen, Wang, Tongkun, Wang, Zhoujia, Yu, Yaqing, Peng, Guangneng, Huang, Kehe, Huang, Liuyu, Wang, Yufei, Chen, Zeliang
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 24.02.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-γ) assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-γ responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB) or BAB1_1688 (AsnC) plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: YW ZC LH. Performed the experiments: SF JX XL YX YQ XD SY YB YC TW ZW YW ZC. Analyzed the data: YW ZC SF JX XL YX. Contributed reagents/materials/analysis tools: YY GP KH. Wrote the paper: YW ZC.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0029552